BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20251201T100323EST-8545RiSSNI@132.216.98.100 DTSTAMP:20251201T150323Z DESCRIPTION:Supported by the Lister Family Engaged Science Initiative\, the Lister Science Chats connects members of the community through live scien ce talks with researchers from the 9IÖÆ×÷³§Ãâ·Ñ Faculty of Agricultural and Envi ronmental Sciences. This chat features three Macdonald Campus graduate stu dents giving an engaging 10-minute talk on their research and will conclud e with a Q&A period.    \n\nNo registration required. Join us live on ZOOM \n\nSpeakers:\n\nAna Madrigal\, PhD candidate\, Institute of ParasitologyP arasites: a novel treatment for rheumatoid arthritis \n\nParasitic infecti ons have been linked to lower incidences of inflammatory and autoimmune di seases. More specifically\, Helminths have been proven to have anti-inflam matory immune regulation capabilities. We want to test whether H. polygyru s and its products can lower inflammation in a mouse model of rheumatoid a rthritis (RA). Through the extracting of these products\, we could find a  component that could be used as treatment against RA.\n\nDaniel Moses\, MS c student\, Institute of ParasitologyStructural analysis of Kinetoplastid RNA Editing Ligase 1\n\nParasites cause millions of deaths a year. My rese arch focuses on an essential protein in Kinetoplastid parasites KREL1. I a imed to narrow down specific parts of this protein that is crucial for fun ction. Four amino acids of KREL1 have proven to be an attractive target fo r drug therapy. \n\nMojtaba Rostamighadi\, PhD candidate\, Institute of Pa rasitologyFinding novel drugs for Kinetoplastid diseases \n\nTriTryps dise ases are devastating parasitic neglected infections caused by Leishmania s pp.\, Trypanosoma cruzi and Trypanosoma brucei. They cause high rates of m orbidity and mortality in tens of millions of patients in endemic areas\, with cases of Chagas’ disease recently reported in North America. Due to t he toxicity and parasite drug resistance to the current available treatmen ts\, developing novel drugs that selectively inhibit essential parasite-sp ecific pathways/proteins is vital. \n DTSTART:20210527T200000Z DTEND:20210527T210000Z LOCATION:Online SUMMARY:Lister Science Chats: The World of Parasites URL:/macdonald/channels/event/lister-science-chats-wor ld-parasites-330956 END:VEVENT END:VCALENDAR